CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 93 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $612,000 | -0.8% | 48,453 | -22.9% | 0.00% | 0.0% |
Q3 2020 | $617,000 | +115.0% | 62,853 | +117.9% | 0.00% | 0.0% |
Q2 2020 | $287,000 | +46.4% | 28,850 | +30.4% | 0.00% | 0.0% |
Q1 2020 | $196,000 | +53.1% | 22,126 | +59.2% | 0.00% | – |
Q4 2019 | $128,000 | -97.1% | 13,900 | -95.3% | 0.00% | -100.0% |
Q3 2018 | $4,420,000 | -12.9% | 297,864 | -1.3% | 0.01% | -16.7% |
Q2 2018 | $5,077,000 | -24.1% | 301,650 | +3.3% | 0.01% | -20.0% |
Q1 2018 | $6,686,000 | +137.8% | 291,950 | +168.6% | 0.02% | +114.3% |
Q4 2017 | $2,812,000 | – | 108,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |